ConductScience.org, home

Paper39476205

miR-128-3p suppresses tumor growth and enhances chemosensitivity in tongue squamous cell carcinoma through MAP2K7 targeting.

Gupta P and 1 other. Mol Biol Rep, 2024. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. miR-128-3p suppresses tumor growth and enhances chemosensitivity in tongue squamous cell carcinoma through MAP2K7 targeting. Papers, record 39476205. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39476205

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
miR-128-3p suppresses tumor growth and enhances chemosensitivity in tongue squamous cell carcinoma through MAP2K7 targeting.
PubMed
Journal
Mol Biol Rep
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
1.32, provisional
iCite
Revised in PubMed
2026-11-01
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gupta PPooja
2Mallick BBibekanand

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MicroRNAsMajor topic
Tongue NeoplasmsMajor topic
Cell ProliferationMajor topic
Gene Expression Regulation, NeoplasticMajor topic
Epithelial-Mesenchymal TransitionMajor topic
Drug Resistance, NeoplasmMajor topic
CisplatinMajor topic
Cell MovementMajor topic
Carcinoma, Squamous CellMajor topic
Humans
Cell Line, Tumor
Animals
MAP Kinase Kinase Kinases
MAP Kinase Signaling System
Apoptosis
Mice
MAP Kinase Kinase Kinase 7

Source PubMed

Download CSV of topics

References71

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136688618Integrative analysis of small non-coding RNAs predicts a piRNA/miRNA-CCND1/BRAF/HRH1/ATXN3 regulatory circuit that drives oncogenesis in glioblastoma.Mol Omics2023https://conductscience.org/library/papers/36688618PubMed
232650236Cell Type Impacts Accessibility of mRNA to Silencing by RNA Interference.Mol Ther Nucleic Acids2020https://conductscience.org/library/papers/32650236PubMed
333991762MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells.Tissue Cell2021https://conductscience.org/library/papers/33991762PubMed
431918270MiR-155-5p promotes oral cancer progression by targeting chromatin remodeling gene ARID2.Biomed Pharmacother2020https://conductscience.org/library/papers/31918270PubMed
531639019The Jun N-terminal kinases signaling pathway plays a "seesaw" role in ovarian carcinoma: a molecular aspect.J Ovarian Res2019https://conductscience.org/library/papers/31639019PubMed
633796026Insight Into the Prospects for RNAi Therapy of Cancer.Front Pharmacol2021https://conductscience.org/library/papers/33796026PubMed
722870247Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancer.PLoS One2012https://conductscience.org/library/papers/22870247PubMed
828260044microRNA-125b reverses the multidrug resistance of nasopharyngeal carcinoma cells via targeting of Bcl-2.Mol Med Rep2017https://conductscience.org/library/papers/28260044PubMed
937215991Inhibition of JNK/c-Jun-ATF2 Overcomes Cisplatin Resistance in Liver Cancer through down-Regulating Galectin-1.Int J Biol Sci2023https://conductscience.org/library/papers/37215991PubMed
1036255066miRNome-transcriptome analysis unveils the key regulatory pathways involved in the tumorigenesis of tongue squamous cell carcinoma.Brief Funct Genomics2022https://conductscience.org/library/papers/36255066PubMed
1125791601Dual luciferase gene reporter assays to study miRNA function.Methods Mol Biol2015https://conductscience.org/library/papers/25791601PubMed
1230277613MiR-125b suppresses the carcinogenesis of osteosarcoma cells via the MAPK-STAT3 pathway.J Cell Biochem2019https://conductscience.org/library/papers/30277613PubMed
1329516950Mechanisms correlated with chemotherapy resistance in tongue cancers.J Cancer Res Ther2018https://conductscience.org/library/papers/29516950PubMed
1431579105MKK7, the essential regulator of JNK signaling involved in cancer cell survival: a newly emerging anticancer therapeutic target.Ther Adv Med Oncol2019https://conductscience.org/library/papers/31579105PubMed
1537473805FDFT1 repression by piR-39980 prevents oncogenesis by regulating proliferation and apoptosis through hypoxia in tongue squamous cell carcinoma.Life Sci2023https://conductscience.org/library/papers/37473805PubMed
1634645978A highly annotated database of genes associated with platinum resistance in cancer.Oncogene2021https://conductscience.org/library/papers/34645978PubMed
1731078043MiR-128-3p suppresses breast cancer cellular progression via targeting LIMK1.Biomed Pharmacother2019https://conductscience.org/library/papers/31078043PubMed
1822796517Subcellular targets of cisplatin cytotoxicity: an integrated view.Pharmacol Ther2012https://conductscience.org/library/papers/22796517PubMed
1932334405Epithelial-Mesenchymal Transition in Cancer: A Historical Overview.Transl Oncol2020https://conductscience.org/library/papers/32334405PubMed
2028351566MicroRNAs in human tongue squamous cell carcinoma: From pathogenesis to therapeutic implications.Oral Oncol2017https://conductscience.org/library/papers/28351566PubMed

See all 71 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42436998Chlorotoxin suppresses melanoma vasculogenic mimicry via LINC01235/miR-128-3p/YY1/ VEGFR2/NRP1 axis.iScience2026https://conductscience.org/library/papers/42436998PubMed
39982595The impact of the ATP-binding cassette (ABC) transporter family on multidrug resistance in head and neck tumors.Mol Biol Rep2025https://conductscience.org/library/papers/39982595PubMed
39808313MiRNAs: main players of cancer drug resistance target ABC transporters.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/39808313PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
JUN3725PubTator's text mininghttps://conductscience.org/library/genes/3725NCBI Gene
MAP2K75609PubTator's text mininghttps://conductscience.org/library/genes/5609NCBI Gene
MAPK85599PubTator's text mininghttps://conductscience.org/library/genes/5599NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39476205

GET https://conductscience.org/api/papers/v1/39476205/references?page=2